Affymetrix, Inc. (NASDAQ:AFFX) will speak at the 28th Annual JPMorgan Healthcare Conference on Thursday, January 14. Presenting will be Affymetrix President and Chief Executive Officer Kevin King. Mr. King will begin his presentation at 9:00 am PT that morning.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
Those unable to attend the event may listen to a live webcast of the event on the company’s website, http://www.affymetrix.com/. The webcast will be on the Webcast Archive page of the Investors section. It will remain on the site for thirty days following the end of the presentation.
Affymetrix, Inc. is engaged in the development, manufacture, sale and service of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets. The markets for the Company’s products include all aspects of molecular biology research in the life sciences, including basic human disease research, genetic analysis, pharmaceutical drug discovery and development, pharmacogenomics (research relating to how a person's genes affect the body's response to drug treatments), toxicogenomics and molecular diagnostics. Its integrated GeneChip microarray platform includes disposable deoxyribonucleic acid (DNA) probe arrays (chips) consisting of nucleic acid sequences set out in an ordered, high-density pattern, certain reagents for use with the probe arrays, a scanner and other instruments used to process the probe arrays, and software to analyze and manage genomic or genetic information obtained from the probe arrays.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
